A case study of radiotherapy planning for a bilateral metal hip prosthesis prostate cancer patient.

[1]  R. Henriksson,et al.  Planning of radiotherapy for patients with hip prosthesis. , 1991, International Journal of Radiation Oncology, Biology, Physics.

[2]  S. Schild,et al.  Radiotherapy treatment planning for prostate cancer in patients with prosthetic hips. , 1992, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[3]  G. Ibbott,et al.  Prostatic thermoluminescent dosimeter analysis in a patient treated with 18 MV X rays through a prosthetic hip. , 1993, International journal of radiation oncology, biology, physics.

[4]  E. Feuer,et al.  Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. , 1999, Journal of the National Cancer Institute.

[5]  R. Alecu,et al.  Traditional and MLC based dose compensator design for patients with hip prostheses undergoing pelvic radiation therapy. , 1999, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[6]  D. Grignon,et al.  Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials. , 2000, International journal of radiation oncology, biology, physics.

[7]  T. Eng.  Dose attenuation through a titanium alloy hip prosthesis. , 2000, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[8]  M. Carolan,et al.  Effect of hip prostheses on radiotherapy dose. , 2000, Australasian radiology.

[9]  J. Kung,et al.  Intensity-modulated radiotherapy for a prostate patient with a metal prosthesis. , 2001, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[10]  J. Agapito.  Radical radiation therapy for carcinoma of the prostate in patients with a single hip prosthesis: a technique analysis using dose-volume histograms. , 2001, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[11]  A. Markoe,et al.  Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). , 2002, International journal of radiation oncology, biology, physics.

[12]  P. Keall,et al.  Dosimetric considerations for patients with HIP prostheses undergoing pelvic irradiation. Report of the AAPM Radiation Therapy Committee Task Group 63. , 2003, Medical physics.

[13]  John C Roeske,et al.  Intensity-modulated radiation therapy for prostate cancer. , 2003, Clinical prostate cancer.

[14]  A. Markoe,et al.  Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II. , 2003, International journal of radiation oncology, biology, physics.

[15]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.